Social and behavioral determinants of attitudes towards and practices of hepatitis B vaccine birth dose in Vietnam |
| |
| Institution: | 1. Hanoi Medical University, No 1 Ton That Tung-Dong Da, Hanoi 116001, Viet Nam;2. ORISE Fellow, Global Immunization Division, US Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329, USA;3. Expanded Program on Immunization, National Institute of Hygiene and Epidemiology, So 1 pho Yec Xanh, Pham Dinh Ho, Hai Ba Trung, Hanoi 100000, Viet Nam;4. Hai Phong Centers for Disease Control, Hai Phong, Viet Nam;5. World Health Organization Representative Office for Vietnam, P.O. Box 52, Hanoi, Viet Nam;6. Global Immunization Division, US Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329, USA;1. National Immunization Programme, Chinese Center for Disease Control and Prevention, No. 27 Nanwei Road, Beijing 100050, China;1. Department of Orthopaedic Surgery, National University Health System, Singapore;2. Department of Cardiothoracic Surgery, National Heart Centre Singapore, Singapore;3. Department of Emergency Medicine, Singapore General Hospital, Singapore;4. Division of Rheumatology, University Medicine Cluster, National University Health System, Singapore;5. Saw Swee Hock School of Public Health, Yong Loo Lin School of Medicine, National University of Singapore, Singapore;1. Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA;2. Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;3. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;4. Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;5. Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, China;1. Department of pathology and Laboratory Medicine, Center for Viral Oncology, University of Kansas Medical Center, Kansas City, KS, United States of America;2. State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen, Fujian, 361102, PR China;3. University of Southern California, Los Angeles, CA, United States of America;4. Guangzhou Blood Center, Guangzhou, Guangdong, China;5. Center for Molecular Biomedicine, School of Medicine, University of Medicine and Pharmacy in Ho Chi Minh City, Ho Chi Minh City, Vietnam;6. Molecular Diagnostic Section, The NK-BIOTEK Laboratory, Ho Chi Minh City, Vietnam;7. Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA, United States of America;8. Department of Pathology, National Institute of Infectious Diseases, Tokyo 162-8640, Japan;1. Department of Obstetrics and Gynaecology, Monash University, Melbourne, Australia;2. MMGH Consulting, Zurich, Switzerland;3. Departments of Pediatrics, Section of Infectious Diseases, and Molecular Virology and Microbiology, Baylor College of Medicine, Houston TX, USA;4. Department of Maternal, Newborn, Child, Adolescent Health and Ageing, Geneva, Switzerland;5. Independent Consultant, McKing Consulting, Geneva, Switzerland;6. Department of Immunization, Vaccines and Biologicals (IVB), World Health Organization, Geneva, Switzerland;9. Medical Research Council: Respiratory and Meningeal Pathogens Research Unit and Department of Science and Technology/ National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa;10. Department of Anthropology University of Pennsylvania, Philadelphia, USA;11. Department of Sexual and Reproductive Health and Research including UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, WHO, Geneva, Switzerland;12. Swiss Tropical and Public Health Institute and University of Basel, Basel, Switzerland |
| |
| Abstract: | BackgroundHepatitis B virus (HBV) infection is a significant public health issue in Vietnam. Our goal was to understand the determinants of attitudes towards and practices of hepatitis B vaccine birth dose (HepB-BD) in certain regions of Vietnam.MethodA rapid qualitative assessment was conducted in three geographically diverse provinces that reported low coverage (<50%) of HepB-BD. Using purposive sampling of participants, 29 focus group discussions and 20 in-depth interviews were held with caregivers (n = 96), healthcare providers (n = 75), and healthcare administrators (n = 16). Summary notes from these were translated, and inductive coding was used to derive themes. The SAGE Vaccine Hesitancy Determinants Matrix was used as a theoretical framework to organize barriers and facilitators associated with the themes into three levels of influence.ResultsAt the individual and group level, caregivers who had higher levels of knowledge about HepB-BD sought the vaccine proactively, while others with lower knowledge faced barriers to the vaccine. Some caregivers reported a negative attitude toward health services because of a language barrier or had generalized concerns about HepB-BD due to media reporting of the past adverse events. Distress arising from potential adverse events was equally common among healthcare providers. At the contextual level, the physical environment made it difficult for caregivers to access healthcare facilities and for providers to conduct outreach. Home births posed a challenge for timely administration of HepB-BD, while health facility births facilitated it. Vaccination-specific barriers included misinterpretation of pre-vaccination screening criteria and asking for the consent of caregivers. Inadequate resources for service delivery negatively influenced HepB-BD attitudes and practices.ConclusionGiven the diversity of barriers associated with attitudes towards and practices of HepB-BD in the three provinces, tailored interventions will be necessary for both demand- and supply-side factors. Rural areas, often with more home births and geographic barriers, may require focused attention. |
| |
| Keywords: | Hepatitis B vaccine Birth dose Vietnam Hesitancy Demand |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
